Cost-Utility Analysis of Survival with Epoetin-Alfa versus Placebo in Stage IV Breast Cancer

Author： Martin S.C.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.21, Iss.16, 2003-01, pp. : 1153-1169

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

SC epoetin-alfa cost saving vs IV route in anaemia

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 383, 2002-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Epoetin alfa cost effective in breast cancer with anaemia

By  

Inpharma, Vol. 1, Iss. 1413, 2003-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Cost-Utility Analysis of Primary Prophylaxis versus Treatment On-Demand for Individuals with Severe Haemophilia

By Miners A.H.  

PharmacoEconomics, Vol. 20, Iss. 11, 2002-01 ,pp. : 759-774

Adis International

Access to resources Recommend Favorite

A Cost-Utility Analysis of Losartan versus Atenolol in the Treatment of Hypertension with Left Ventricular Hypertrophy

By Anis Aslam H.   Sun Huiying  

PharmacoEconomics, Vol. 24, Iss. 4, 2006-01 ,pp. : 387-400

Adis International

Access to resources Recommend Favorite

A Cost-Utility Analysis of Microwave Endometrial Ablation versus Thermal Balloon Endometrial Ablation

By Kilonzo Mary M.   Sambrook Alison M.   Cook Jonathan A.   Campbell Marion K.   Cooper Kevin G.  

Value in Health, Vol. 13, Iss. 5, 2010-08 ,pp. : 528-534

Blackwell Publishing

Access to resources Recommend Favorite